Month: September 2024

ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

Written by Customer Service on September 9, 2024. Posted in Public Companies.

If approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The submission of neffy 1 mg sNDA follows FDA approval on August 9, 2024, of neffy (2 mg) for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh 30 kg (66 lbs.) or greater SAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis, announced today the submission of a supplemental New Drug Application (sNDA) for neffy® 1 mg for the treatment of Type I Allergic Reactions, including anaphylaxis, in children who weigh 15 to 30 kg (33-66 lbs.). Pharmacokinetic...

SL Green Realty Corp. to Release Third Quarter 2024 Financial Results After Market Close on October 16, 2024

Written by Customer Service on September 9, 2024. Posted in Public Companies.

Conference Call to be Held on October 17, 2024 at 2:00pm ET NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that it will release its earnings for the third quarter of 2024 on Wednesday, October 16, 2024 after market close. The Company’s executive management team, led by Marc Holliday, Chairman and Chief Executive Officer, will host a conference call and audio webcast on Thursday, October 17, 2024 at 2:00pm ET to discuss the financial results. Simultaneous with the earnings release, supplemental data will be made available in the Investors section of the SL Green Realty Corp. website at https://slgreen.com under “Financial Reports”. The live conference call will be webcast in listen-only mode and a replay will be available in the Investors...

Calavo Growers, Inc. Announces Third Quarter 2024 Financial Results, Dividend Increase

Written by Customer Service on September 9, 2024. Posted in Earnings Releases And Operating Results.

SANTA PAULA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today reported its financial results for the fiscal third quarter ended July 31, 2024. Third Quarter Financial Overview Introductory Note: In the first quarter of 2024, we concluded that the Fresh Cut (formerly RFG) business meets the requirements to be classified as held for sale and discontinued operations. As a result, the financial results of that business are reported as discontinued operations in this press release. The divestiture of the Fresh Cut business occurred on August 15, 2024. Prior to the decision to divest our Fresh Cut business, the Company’s Prepared reporting segment included the Fresh Cut business unit and our guacamole...

NBT Bancorp Inc. and Evans Bancorp, Inc. Announce Strategic Partnership

Written by Customer Service on September 9, 2024. Posted in Mergers And Acquisitions.

Merger Will Extend NBT’s Growing Footprint to Western New York, Bring Next Generation of Community Banking Into Region NORWICH, N.Y. and WILLIAMSVILLE, N.Y., Sept. 09, 2024 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT”) (NASDAQ: NBTB) and Evans Bancorp, Inc. (“Evans”) (NYSE American: EVBN) today announced they have entered into a definitive agreement pursuant to which Evans will merge with and into NBT. This merger will bring together two highly respected banking companies and extend NBT’s growing footprint into Western New York. “We are enthusiastic about this opportunity to partner with Evans and are confident it is a high quality and incredibly impactful way to expand NBT’s presence into Western New York,” said NBT President and Chief Executive Officer Scott A. Kingsley. “Adding the greater Buffalo and Rochester communities to...

Matrix Service Company Reports Fourth Quarter and Full-Year Fiscal 2024 Results; Issues Fiscal 2025 Revenue Guidance

Written by Customer Service on September 9, 2024. Posted in Earnings Releases And Operating Results.

TULSA, Okla., Sept. 09, 2024 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX), a leading North American industrial engineering, construction, and maintenance contractor, today announced results for the fourth quarter and year ended June 30, 2024. FOURTH QUARTER FISCAL 2024 RESULTS(all comparisons versus the prior year quarter unless otherwise noted)Total backlog of $1.4 billion, +31% on a year-over-year basis Total project awards in the quarter of $175.9 million, resulting in a book-to-bill ratio of 0.9x Revenue of $189.5 million Net loss per share of $(0.16) versus $(0.01); adjusted net loss per share of $(0.14)(1) versus $(0.11) Adjusted EBITDA of $0.2 million(1) versus $2.2 million Cash flow from operations of $47.0 million Liquidity at June 30, 2024 of $169.6 million with no outstanding debtFULL-YEAR FISCAL 2024...

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

Written by Customer Service on September 9, 2024. Posted in Earnings Releases And Operating Results.

— Recorded First Quarter Revenue of $40.2 Million — — Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million — — Maintained FY2025 Revenue Guidance of Between $160 Million and $168 Million — TUSTIN, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the first quarter ended July 31, 2024. Highlights from the Quarter Ended July 31, 2024, and Other Events: “Our first quarter continued the strong momentum we have seen since the completion of our expansion program. We are encouraged by the...

Mission Produce™ Announces Fiscal 2024 Third Quarter Financial Results

Written by Customer Service on September 9, 2024. Posted in Earnings Releases And Operating Results.

Year-to-date momentum continues with ongoing strength of the Marketing & Distribution segment Operating cash flow for the first nine months of fiscal 2024 increased by $62.7 million versus the prior year period OXNARD, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today reported its financial results for the fiscal third quarter ended July 31, 2024. Fiscal Third Quarter 2024 Financial Overview:Total revenue increased 24% to $324.0 million compared to the same period last year Net income of $12.4 million, or $0.17 per diluted share, compared to $6.6 million, or $0.09 per diluted share, for the same period last year Adjusted net income...

Abivax presents first-half 2024 financial results

Written by Customer Service on September 9, 2024. Posted in Earnings Releases And Operating Results.

Abivax presents first-half 2024 financial resultsCash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, announces today its 2024 half-year financial results, as of June 30, 2024. The interim financial statements for the first half of 2024, approved by the Company’s Board of Directors on September 5, 2024, have been reviewed by the Company’s external auditors. Abivax recently provided updates on its business and operational goals in press releases published on July 15, 2024 (“Abivax...

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Written by Customer Service on September 9, 2024. Posted in Public Companies.

WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) — Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the position of President, U.S. Surgical and Global Product and Enabling Technologies. Mr. Czartoski has direct responsibility for the Company’s U.S. Surgical business, including the global surgical product engine and enabling technologies. He reports to Louie Vogt, Group President of Enovis’ Reconstructive (Recon) Business Group. Mr. Czartoski is a successful MedTech executive with over 22 years of experience at Depuy Synthes, the Orthopaedics Company of Johnson & Johnson, where he progressed in leadership roles of increasing responsibility. In his most recent role as President of Depuy Synthes, U.S., Mr. Czartoski led the Company’s...

Planisware recognized as a Leader in 2024 Gartner® Magic Quadrant™ for Adaptive Project Management & Reporting report

Written by Customer Service on September 9, 2024. Posted in Public Companies.

Planisware recognized as a Leader in 2024 Gartner® Magic Quadrant™ for Adaptive Project Management & Reporting report Paris, France, September 9, 2024 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today it has been named a Leader in the 2024 Gartner “Magic Quadrant for Adaptive Project Management and Reporting report.1” Of the 13 companies evaluated, Planisware was recognized as a Leader based on “Completeness of Vision” and “Ability to Execute”. Loïc Sautour, CEO of Planisware, commented: ”Planisware’s goal has always been to align our product strategy with customers’ evolving needs, placing the end user at the center of our roadmap. We believe this recognition highlights that commitment to empowering organizations to tackle everything from decision-making and prioritization...

Month: September 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals